Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...
Novavax Stock Plummets as FDA Pauses Clinical Trial on Safety Concerns
The regulator placed a clinical hold on its Covid-19-influenza combination vaccine after one person reported nerve damage.
Novavax reports FDA placed clinical hold on IND for COVID-flu combo vaccine
Novavax announced that the U.S. Food and Drug Administration has placed a clinical hold on Novavax’s Investigational New Drug ...
FierceBiotech1d
FDA puts Novavax's phase 3 plan for pair of vaccine programs on hold over nerve disease case
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
Business Insider1d
Cautious Optimism for Novavax Amid Clinical Hold Challenges
Roger Song has given his Buy rating due to a combination of factors that, despite current challenges, present potential upside for Novavax. The company is dealing with a clinical hold on its CIC ...
kalkinemedia16h
Novavax, Inc. (NASDAQ:NVAX) Shares Tumbled on Wednesday Following Clinical Hold on Flu Combination Vaccine
Highlights,Novavax faces a clinical hold following the report of motor neuropathy in a trial participant nearly two years ...